Physician profile
Lenny Gets
NPI 1841934049
$2,081.49
in general payments reported to CMS, 2019-2025
16 companies · $668 in 2025
The $668 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $242 · 2023: $136 · 2024: $1,035 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,839.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $571.10 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $538.49 | 2022-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $269.78 | 2022-2024 | Caplyta |
| Axsome Therapeutics, INC. | $163.59 | 2024-2025 | Sunosi, Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $133.58 | 2024-2025 | Trintellix |
| Lundbeck LLC | $85.91 | 2024-2025 | Rexulti |
| Neos Therapeutics, LP | $68.99 | 2024-2025 | Adzenys Xr-Odt |
| Bausch Health US, LLC | $67.30 | 2024-2025 | Aplenzin, Wellbutrin |
| Alkermes, INC. | $35.52 | 2024-2025 | Aristada, Lybalvi |
| E.R. Squibb & Sons, L.L.C. | $33.32 | 2024-2025 | Cobenfy |
| Collegium Pharmaceutical, INC. | $32.04 | 2025 | Jornay Pm |
| Tris Pharma INC | $18.30 | 2025 | Dyanavel Xr |
| Teva Pharmaceuticals USA, INC. | $17.50 | 2024 | Austedo Xr |
| Vanda Pharmaceuticals INC. | $15.99 | 2024 | Hetlioz, Fanapt |
| Almatica Pharma LLC | $15.47 | 2025 | Loreev Xr |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $14.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lenny Gets listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.